Compare Moderna, Inc. (MRNA) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Ryanair Holdings plc — how do they compare? Moderna, Inc. trades at $225 (market cap $78.65B), while Ryanair Holdings plc trades at $54.24 (market cap $27.11B). The key difference: Moderna, Inc. is far larger — about 2.9× Ryanair Holdings plc's market cap, and Ryanair Holdings plc pays a 1.66% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Ryanair Holdings plc for 72 Days on average.
| MRNA | RYAAY | |
|---|---|---|
Market Cap | $78.65B | $27.11B |
Volume | 37,373,437 | 2,427,380 |
Sector | Health | Industrials |
52-Week High | $225.00 | $73.82 |
52-Week Low | $22.36 | $51.95 |
Typical Hold Time | 59 Days | 72 Days |
Enterprise Value | $74.80B | $24.18B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $197.00, up 0.26% today, reflecting a strong 2026 rally. The stock is technically bullish, with moving averages signaling strength and key support at $194. Fundamentally, revenue has declined from pandemic peaks to $1.92 billion in 2025, with net losses widening to -$2.82 billion, though recent quarters have beaten EPS estimates. The company's inclusion in the Nasdaq-100 index effective October 9, 2026, adds a positive catalyst. Analyst sentiment is mixed, with a consensus price target of $115.70 but a high target of $245.00, indicating divergent views on valuation after the stock's significant run-up.
The outlook for Moderna hinges on its pipeline beyond COVID-19, particularly cancer vaccines, but high valuation ratios (P/S of 35.08) and persistent losses pose risks. Upside potential exists if new products gain traction, yet investors face volatility from clinical trial outcomes and competitive pressures. The stock's proximity to 52-week highs suggests caution amid profit-taking signals from some analysts.
RYAAY trades at $54.04, down 3.5% on the day, with a bearish technical signal from moving averages. The company reported revenue of $13.95 billion in 2025 and net income of $1.61 billion, with a P/E ratio of 13.43. Recent earnings have been mixed, with a miss in Q2 2026. News highlights include CEO commentary on Boeing MAX 10 delays and concerns over fuel costs impacting future airfares.
The stock presents a valuation opportunity with low P/E and EV/EBITDA multiples, but faces near-term headwinds from volatile fuel prices and reduced traffic forecasts. Analyst consensus is moderately bullish, with 65% buy ratings, though technical indicators suggest caution. Key risks include oil price sensitivity and competitive pressures in the European airline sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
